Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring.

Sado A, Tomaszewska M, Wójcik S, Rulkiewicz A

Open source

DOI
10.3390/diagnostics16091314
Published
2026 Apr 27
Container
Diagnostics (Basel, Switzerland)
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics16091314,
  title = {Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring.},
  author = {Sado A and Tomaszewska M and Wójcik S and Rulkiewicz A},
  year = {2026},
  journal = {Diagnostics (Basel, Switzerland)},
  doi = {10.3390/diagnostics16091314},
  url = {https://doi.org/10.3390/diagnostics16091314}
}

RIS

TY  - JOUR
TI  - Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring.
AU  - Sado A
AU  - Tomaszewska M
AU  - Wójcik S
AU  - Rulkiewicz A
PY  - 2026
JO  - Diagnostics (Basel, Switzerland)
DO  - 10.3390/diagnostics16091314
UR  - https://doi.org/10.3390/diagnostics16091314
ER  - 

APA

A, S., M, T., S, W., & A, R. (2026). Skin as a Metabolic Organ: Dermatologic Markers of Morbid Obesity and Their Role in Risk Stratification and Treatment Monitoring.. Diagnostics (Basel, Switzerland). https://doi.org/10.3390/diagnostics16091314

Source records